The global xenotransplantation market is anticipated to witness a growth of steady CAGR in the forecast period, 2023-2027. Factors such as the shortage of organs for human transplantation and the advancements in organ transplantation technology are primarily driving the demand for the global xenotransplantation market. Also, the increased prevalence of chronic diseases and the high-end investments by the concerned authorities in research and development activities to find novel transplantation technologies are expected to create lucrative growth opportunities for the global xenotransplantation market players over the next five years.

Increased Prevalence of Chronic Diseases Drives the Market Demand

Due to the adoption of unhealthy eating habits and sedentary lifestyles, and increased levels of pollution across the globe, human beings are becoming more prone to getting affected by a number of diseases. There is an increased prevalence and incidence of chronic diseases such as cancer, chronic obstructive pulmonary disease, lupus, and kidney failure across the globe. These diseases and disorders disrupt the normal functioning of the organ and result in organ failure. Doctors and healthcare professionals recommend the transplantation of organs to save human lives or replace the ill-functioning organs with a newer one. According to the United Network for Organ Sharing (UNOS), which serves as an organ procurement and transplantation network stated that 41,354 organ transplants were performed in the United States, which is a 5.9 percent increase from 2020. People are becoming more aware of their current health condition and are willing to spend more to live a healthy life. Also, the government of different countries are spending significant amounts and are creating awareness about the benefits of organ transplantation. Therefore, the rise in the incidence of chronic diseases and the discovery of technologies that can lower the mortality rates due to organ failure are expected to fuel the demand for the global xenotransplantation market over the forecast period.

Shortage of Organs for Transplantation in Humans Supports the High Market Demand

The demand for organ transplantation increased all over the globe due to the growing incidence of organ failure and surge in success and greater outcome in posttransplant operation. The unavailability of adequate organs for transplantation to meet the existing demand results in major organ shortage crisis. There has been increase in the number of patients on transplant waiting list as well as the number of patients dying while on the waiting list. However, the shortage of adequate organs for transplantation to meet the existing demand results in major organ shortage crisis. Organ shortage deprives the patients from living a healthy life and increases the cost of medical care for the affected individuals. Xenotransplantation is a process which provides the opportunity to transplant organs from non-human animals in shortage of organ shortage crisis. Thus, the ongoing developments in organ transplantation technology to fulfill the demand of donors is expected to propel the global xenotransplantation market growth over the next five years.


Click here to download the sample

Market Segmentation

The global xenotransplantation market is segmented into animal type, xeno product, end user, regional distribution, and competitive landscape. Based on animal type, the market is divided into pig, rabbit, baboon, and others. Based on xeno product, the market is divided into organs, tissues, and cells. The organs segment is further fragmented into kidney, liver, heart, cornea, others. Based on end user, the market is divided into river hospitals, transplant centers, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among North American region, Asia-Pacific region, European region, South American region, and Middle East & African region. In terms of country, the United States is expected to be a lucrative market owing to the adoption of advanced technologies for research and development activities.

Market Players

United Therapeutics Corporation, Immerge BioTherapeutics, Inc, eGenesis, Inc., Infigen, Inc., NZeno Limited, recombinetics (Makana Therapeutics), Miromatrix Medical Inc., Optipharm Co. Ltd, Xeno Transplants Corporation, Smithfield Foods, Inc. are the major market players operating in the global xenotransplantation market.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Animal Type

·         Xeno Product

·         End User

Regional scope

North America; Asia Pacific; Europe; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; China; India; Japan; Australia; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Columbia; South Africa; UAE; Saudi Arabia

Key companies profiled

United Therapeutics Corporation, Immerge BioTherapeutics, Inc, eGenesis, Inc., Infigen, Inc., NZeno Limited, recombinetics (Makana Therapeutics), Miromatrix Medical Inc., Optipharm Co. Ltd, Xeno Transplants Corporation, Smithfield Foods, Inc.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global xenotransplantation market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Xenotransplantation Market, By Animal Type:
    • Pig
    • Rabbit
    • Baboon
    • Others
  • Xenotransplantation Market, By Xeno Product:
    • Organs
      • Kidney
      • Liver
      • Heart
      • Cornea
      • Others
    • Tissues
    • Cells
  • Xenotransplantation Market, By End User:
    • Hospitals
    • Transplant Centers
    • Others
  • Xenotransplantation Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • Europe
      • Germany
      • France
      • United Kingdom
      • Spain
      • Italy
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa

§  South Africa

§  UAE

§  Saudi Arabia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global xenotransplantation market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global xenotransplantation market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Xenotransplantation Market

5.    Voice of Customer

5.1.  Xenotransplantation Awareness

5.2.  Factors Contributing Switch to Xenotransplantation

5.3.  Preference, By Animal Type

5.4.  Barriers to Adoption of Xenotransplantation

6.    Clinical Trial Analysis

7.    Patent Analysis

8.    Successful Xenotransplantation Case Studies

9.    Global Xenotransplantation Market Outlook

9.1.  Market Size & Forecast

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Animal Type (Pig, Rabbit, Baboon, Others)

9.2.2.     By Xeno Product (Organs, Tissues, Cells)

9.2.2.1.         By Organs (Kidney, Liver, Heart, Cornea, Others)

9.2.3.     By End User (Hospitals, Transplant Centers, Others)

9.2.4.     By Company (2021)

9.2.5.     By Region

9.3.  Product Market Map

10.  North America Xenotransplantation Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Animal Type (Pig, Rabbit, Baboon, Others)

10.2.2.  By Xeno Product (Organs, Tissues, Cells)

10.2.2.1.      By Organs (Kidney, Liver, Heart, Cornea, Others)

10.2.3.  By End User (Hospitals, Transplant Centers, Others)

10.2.4.  By Country

10.3.              Policy & Regulatory Landscape

10.4.              North America: Country Analysis

10.4.1.  United States Xenotransplantation Market Outlook

10.4.1.1.      Market Size & Forecast

10.4.1.1.1.           By Value

10.4.1.2.      Market Share & Forecast

10.4.1.2.1.           By Animal Type

10.4.1.2.2.           By Xeno Product

10.4.1.2.3.           By End User

10.4.2.  Mexico Xenotransplantation Market Outlook

10.4.2.1.      Market Size & Forecast

10.4.2.1.1.           By Value

10.4.2.2.      Market Share & Forecast

10.4.2.2.1.           By Animal Type

10.4.2.2.2.           By Xeno Product

10.4.2.2.3.           By End User

10.4.3.  Canada Xenotransplantation Market Outlook

10.4.3.1.      Market Size & Forecast

10.4.3.1.1.           By Value

10.4.3.2.      Market Share & Forecast

10.4.3.2.1.           By Animal Type

10.4.3.2.2.           By Xeno Product

10.4.3.2.3.           By End User

11.  Europe Xenotransplantation Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Animal Type (Pig, Rabbit, Baboon, Others)

11.2.2.  By Xeno Product (Organs, Tissues, Cells)

11.2.2.1.      By Organs (Kidney, Liver, Heart, Cornea, Others)

11.2.3.  By End User (Hospitals, Transplant Centers, Others)

11.2.4.  By Country

11.3.              Policy & Regulatory Landscape

11.4.              Europe: Country Analysis

11.4.1.  France Xenotransplantation Market Outlook

11.4.1.1.      Market Size & Forecast

11.4.1.1.1.           By Value

11.4.1.2.      Market Share & Forecast

11.4.1.2.1.           By Animal Type

11.4.1.2.2.           By Xeno Product

11.4.1.2.3.           By End User

11.4.2.  Germany Xenotransplantation Market Outlook

11.4.2.1.      Market Size & Forecast

11.4.2.1.1.           By Value

11.4.2.2.      Market Share & Forecast

11.4.2.2.1.           By Animal Type

11.4.2.2.2.           By Xeno Product

11.4.2.2.3.           By End User

11.4.3.  United Kingdom Xenotransplantation Market Outlook

11.4.3.1.      Market Size & Forecast

11.4.3.1.1.           By Value

11.4.3.2.      Market Share & Forecast

11.4.3.2.1.           By Animal Type

11.4.3.2.2.           By Xeno Product

11.4.3.2.3.           By End User

11.4.4.  Italy Xenotransplantation Market Outlook

11.4.4.1.      Market Size & Forecast

11.4.4.1.1.           By Value

11.4.4.2.      Market Share & Forecast

11.4.4.2.1.           By Animal Type

11.4.4.2.2.           By Xeno Product

11.4.4.2.3.           By End User

11.4.5.  Spain Xenotransplantation Market Outlook

11.4.5.1.      Market Size & Forecast

11.4.5.1.1.           By Value

11.4.5.2.      Market Share & Forecast

11.4.5.2.1.           By Animal Type

11.4.5.2.2.           By Xeno Product

11.4.5.2.3.           By End User

12.  Asia-Pacific Xenotransplantation Market Outlook

12.1.              Market Size & Forecast

12.1.1.  By Value

12.2.              Market Share & Forecast

12.2.1.  By Animal Type (Pig, Rabbit, Baboon, Others)

12.2.2.  By Xeno Product (Organs, Tissues, Cells)

12.2.2.1.      By Organs (Kidney, Liver, Heart, Cornea, Others)

12.2.3.  By End User (Hospitals, Transplant Centers, Others)

12.2.4.  By Country

12.3.              Policy & Regulatory Landscape

12.4.              Asia-Pacific: Country Analysis

12.4.1.  China Xenotransplantation Market Outlook

12.4.1.1.      Market Size & Forecast

12.4.1.1.1.           By Value

12.4.1.2.      Market Share & Forecast

12.4.1.2.1.           By Animal Type

12.4.1.2.2.           By Xeno Product

12.4.1.2.3.           By End User

12.4.2.  India Xenotransplantation Market Outlook

12.4.2.1.      Market Size & Forecast

12.4.2.1.1.           By Value

12.4.2.2.      Market Share & Forecast

12.4.2.2.1.           By Animal Type

12.4.2.2.2.           By Xeno Product

12.4.2.2.3.           By End User

12.4.3.  South Korea Xenotransplantation Market Outlook

12.4.3.1.      Market Size & Forecast

12.4.3.1.1.           By Value

12.4.3.2.      Market Share & Forecast

12.4.3.2.1.           By Animal Type

12.4.3.2.2.           By Xeno Product

12.4.3.2.3.           By End User

12.4.4.  Japan Xenotransplantation Market Outlook

12.4.4.1.      Market Size & Forecast

12.4.4.1.1.           By Value

12.4.4.2.      Market Share & Forecast

12.4.4.2.1.           By Animal Type

12.4.4.2.2.           By Xeno Product

12.4.4.2.3.           By End User

12.4.5.  Australia Xenotransplantation Market Outlook

12.4.5.1.      Market Size & Forecast

12.4.5.1.1.           By Value

12.4.5.2.      Market Share & Forecast

12.4.5.2.1.           By Animal Type

12.4.5.2.2.           By Xeno Product

12.4.5.2.3.           By End User

13.  South America Xenotransplantation Market Outlook

13.1.              Market Size & Forecast

13.1.1.  By Value

13.2.              Market Share & Forecast

13.2.1.  By Animal Type (Pig, Rabbit, Baboon, Others)

13.2.2.  By Xeno Product (Organs, Tissues, Cells)

13.2.2.1.      By Organs (Kidney, Liver, Heart, Cornea, Others)

13.2.3.  By End User (Hospitals, Transplant Centers, Others)

13.2.4.  By Country

13.3.              Policy & Regulatory Landscape

13.4.              South America: Country Analysis

13.4.1.  Brazil Xenotransplantation Market Outlook

13.4.1.1.      Market Size & Forecast

13.4.1.1.1.           By Value

13.4.1.2.      Market Share & Forecast

13.4.1.2.1.           By Animal Type

13.4.1.2.2.           By Xeno Product

13.4.1.2.3.           By End User

13.4.2.  Argentina Xenotransplantation Market Outlook

13.4.2.1.      Market Size & Forecast

13.4.2.1.1.           By Value

13.4.2.2.      Market Share & Forecast

13.4.2.2.1.           By Animal Type

13.4.2.2.2.           By Xeno Product

13.4.2.2.3.           By End User

13.4.3.  Colombia Xenotransplantation Market Outlook

13.4.3.1.      Market Size & Forecast

13.4.3.1.1.           By Value

13.4.3.2.      Market Share & Forecast

13.4.3.2.1.           By Animal Type

13.4.3.2.2.           By Xeno Product

13.4.3.2.3.           By End User

14.  Middle East and Africa Xenotransplantation Market Outlook

14.1.              Market Size & Forecast

14.1.1.  By Value

14.2.              Market Share & Forecast

14.2.1.  By Animal Type (Pig, Rabbit, Baboon, Others)

14.2.2.  By Xeno Product (Organs, Tissues, Cells)

14.2.2.1.      By Organs (Kidney, Liver, Heart, Cornea, Others)

14.2.3.  By End User (Hospitals, Transplant Centers, Others)

14.2.4.  By Country

14.3.              Policy & Regulatory Landscape

14.4.              MEA: Country Analysis

14.4.1.  South Africa Xenotransplantation Market Outlook

14.4.1.1.      Market Size & Forecast

14.4.1.1.1.           By Value

14.4.1.2.      Market Share & Forecast

14.4.1.2.1.           By Animal Type

14.4.1.2.2.           By Xeno Product

14.4.1.2.3.           By End User

14.4.2.  Saudi Arabia Xenotransplantation Market Outlook

14.4.2.1.      Market Size & Forecast

14.4.2.1.1.           By Value

14.4.2.2.      Market Share & Forecast

14.4.2.2.1.           By Animal Type

14.4.2.2.2.           By Xeno Product

14.4.2.2.3.           By End User

14.4.3.  UAE Xenotransplantation Market Outlook

14.4.3.1.      Market Size & Forecast

14.4.3.1.1.           By Value

14.4.3.2.      Market Share & Forecast

14.4.3.2.1.           By Animal Type

14.4.3.2.2.           By Xeno Product

14.4.3.2.3.           By End User

15.  Market Dynamics

15.1.              Drivers

15.2.              Challenges

16.  Market Trends & Developments

17.  SWOT Analysis: Global Xenotransplantation Market

18.  Competitive Landscape (Inclusive of SWOT Analysis of Players Profiled)

18.1.              United Therapeutics Corporation

18.2.              Immerge BioTherapeutics, Inc

18.3.              eGenesis, Inc.

18.4.              Infigen, Inc.

18.5.              NZeno Limited

18.6.              recombinetics (Makana Therapeutics)

18.7.              Miromatrix Medical Inc.

18.8.              Optipharm Co. Ltd

18.9.              Xeno Transplants Corporation

18.10.            Smithfield Foods, Inc.

19. Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com